SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001005477-01-000710
Filing Date
2001-02-07
Accepted
2001-02-07 00:00:00
Documents
1
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLIHAROLD R. WERNERHEALTHCARE PARTNERS III, L.P.HEALTHCARE PARTNERS IV, L.P.HEALTHCARE PARTNERS V, L.P.HEALTHCARE VENTURES II LPHEALTHCARE VENTURES III, L.P.HEALTHCARE VENTURES IV, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LIT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G 0001.txt SC 13G/A 44597
  Complete submission text file 0001005477-01-000710.txt   47116
Mailing Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837
Business Address TWIN TOWERS AT METRO PARK 379 THORNALL AVENUE EDISON NJ 08837 9089064613
HEALTHCARE VENTURES II LP (Filed by) CIK: 0000859649 (see all company filings)

IRS No.: 223015728 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000

Mailing Address EAST ANTON ANDOVER HAMPSHIRE ENGLAND ENGLAND SP10 5RG
Business Address EAST ANTON ANDOVER HAMPSHIRE ENGLAND ENGLAND SP10 5RG X0 1264333455
SHIRE PHARMACEUTICALS GROUP PLC (Subject) CIK: 0000936402 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-55755 | Film No.: 1527170
SIC: 2834 Pharmaceutical Preparations